SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001683168-19-001343
Filing Date
2019-05-02
Accepted
2019-05-02 17:28:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D hwang_sc13d.htm SC 13D 35763
  Complete submission text file 0001683168-19-001343.txt   37164
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Subject) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45691 | Film No.: 19793247
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MARINA BIOTECH, INC. 17870 CASTLETON STREET, SUITE 250 CITY OF INDUSTRY CA 91748
Business Address
Hwang Larn (Filed by) CIK: 0001697480 (see all company filings)

Type: SC 13D